ACETO Corp (ACET) Tops Q4 EPS by 17c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
ACETO Reports Fiscal 2015 Fourth Quarter and Year End Results
September 10, 2015 5:00 PM EDTPORT WASHINGTON, N.Y., Sept. 10, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), a global leader in the marketing, sale and distribution of products for Human Health, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the fourth quarter of fiscal 2015 ended June 30, 2015.
Fiscal 2015 versus Fiscal 2014
Net sales of $547.0 million versus $510.2 million, a 7.2% increase Gross profit of $135.4 million versus $114.7 million, an 18.1% increase Net income of $33.5 million versus $29.0 million, a 15.5% increase Diluted EPS of $1.14 versus $1.02, an 11.8% increase Non-GAAP Adjusted Net Income of $38.9 million versus $34.7 million, a 12.0% increase... More